Código QR (código de barras bidimensional)

Outcomes of the use of the glycosaminoglycan-peptide complex as monotherapy and in combination with diacerein for the treatment of knee osteoarthritis in real-world practice

Background. Slow-acting symptomatic agents (chondroprotectors) in osteoarthritis (OA) combined therapy is a promising approach. Aim. To compare the real-world results of combined therapy with glycosaminoglycan-peptide complex (GPC) and diacerein with GPC monotherapy in treating knee OA. Materi...

ver descrição completa

Na minha lista:
Principais autores: Andrey E. Karateev, Elena Iu. Polishchuk, Alena S. Potapova, Elena V. Matyanova, Ekaterina S. Filatova, Svetlana I. Glukhova, Aleksander M. Lila
Formato: Artigo
Idioma:Russo
Publicado em: ZAO "Consilium Medicum" 2023-05-01
coleção:Consilium Medicum
Assuntos:
osteoarthritis
glycosaminoglycan-peptide complex
diacerein
combination
efficacy
safety
Acesso em linha:https://consilium.orscience.ru/2075-1753/article/viewFile/553441/132691
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados